Advances in Melanoma: From Biology to Therapy

描述（由申请人提供）：拟议的会议，题为“黑色素瘤的进展：从生物学到治疗”，将于2014年9月20日至23日在宾夕法尼亚州费城的Loews费城举行。这次特别会议将讨论调查和有效治疗黑色素瘤的独特问题和挑战。本次会议的目标是将该领域的顶级基础、转化和临床研究人员聚集在一起，讨论如何将基础研究成果有效地转化为临床的新治疗方案。科学会议将包括专家研究人员在主要会议（4小时）上的7次报告和在次要会议（2小时）上的3次报告。专家研究人员的每次报告时长为20-25分钟。此外，为了鼓励年轻的研究人员，每节会议将增加一到两篇15-20分钟的简短演讲，并提供充足的讨论时间。会议将从遗传学、表观遗传学、黑素瘤生物学的进展开始，讨论目前主要问题的治疗反应和耐药原理，最后讨论使用联合治疗的新策略。一个特别的一小时小组讨论将集中讨论黑色素瘤研究中的挑战和机遇。将举行海报会议，让研究人员在非正式的环境中展示和讨论他们的最新研究。本次会议将吸引专注于基础、转化、

DESCRIPTION (provided by applicant): The proposed conference, titled "Advances in Melanoma: From Biology to Therapy," will be held from September 20-23, 2014 at the Loews Philadelphia, Philadelphia, PA. This special conference will address the unique issues and challenges in investigating and effectively treating melanoma. The goal of this conference is to bring together the top basic, translational, and clinical researchers in the field to discuss how basic research findings can be translated effectively into novel treatment options in the clinic. Scientific sessions will consist of seven presentations in major session (four hours) and three presentations in minor (two hours) sessions from expert researchers. Each presentation from expert researchers will be 20-25 minute presentations long. Additionally, to encourage young investigators one to two proffered short talk 15-20 minute will be incorporated in each session with ample time for discussion. Conference will start with presentations covering the advances in genetics, epigenetics, pathogenesis of melanoma biology, leading the discussion into principles of response and resistance to therapy-currently a major problem, concluding the discussion on emerging new strategies of using combination therapy. A special one-hour panel discussion will focus on challenges and opportunities in the melanoma research. Poster sessions will be held to allow investigators to present and discuss their latest research in an informal setting. This conference will appeal to investigators focused on the basic, translational, and clinical aspects of melanoma and will foster collaborative interdisciplinary interactions to stimulate the development of new research and clinical practices. It is expected that this new conference will provide a unique forum for discussions that will further the basic, translational, and clinical goals of the field.